Top list · Boston
617 health startups in Boston have raised money in rounds we track. These are the 50 that have raised the most, $27B between them.
Devoted Health is a technology-driven healthcare company founded in 2017 by brothers Todd and Ed Park.
Founded 2017Waltham, United States$2.1Blast round Nov 2026Blueprint Medicines is a global, fully integrated biopharmaceutical company that invents life-changing medicines.
Founded 2011Cambridge, United States$1.4Blast round Jun 2022WHOOP is a performance optimization system that tracks athlete recovery, training, and sleeping hours to help boost performance.
Founded 2012Boston, United States$1.3Blast round Mar 2026EQRx is a biotechnology company that focuses on re-engineering the process of drug discovery to make them affordable.
Founded 2019Cambridge, United States$1.2Blast round Dec 2021Intarcia Therapeutics develops therapies for diseases that require long-term chronic treatment.
Founded 1997Boston, United States$1.1Blast round Sept 2016Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.
Founded 2016Cambridge, United States$932Mlast round May 2026Oruka Therapeutics is advancing innovative biologics to redefine patient care standards in chronic skin diseases.
Founded -Waltham, United States$880Mlast round Apr 2026Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Founded 2017Cambridge, United States$852Mlast round Jun 2026Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.
Founded 2018Waltham, United States$828Mlast round Jul 2026Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.
Founded 2017Cambridge, United States$799Mlast round Dec 2025Suno, Inc.
Founded 2022Cambridge, United States$750Mlast round Jun 2026Dianthus Therapeutics is a biotech company developing new treatments for serious autoimmune diseases using a more targeted approach.
Founded 2019Waltham, United States$719Mlast round Mar 2026Learn how we’re changing the world of medicine.
Founded 2013Cambridge, United States$675Mlast round Jun 2026Pioneering Medicines is a biotechnology research agency providing biotechnology to life sciences services.
Founded 2000Cambridge, United States$618Mlast round Dec 2017Kailera Therapeutics develops next-generation injectable and oral therapies for chronic weight management.
Founded -Waltham, United States$600Mlast round Oct 2025ElevateBio is a biotechnology company based in Waltham, Massachusetts, founded in 2017.
Founded 2017Waltham, United States$551Mlast round May 2023Lila Sciences is a biotechnology company based in Cambridge, Massachusetts, founded in 2023 through a merger of two projects from Flagship Pioneering.
Founded -Cambridge, United States$551Mlast round Jan 2026Korsana Biosciences develops THETA-enabled antibody therapies for neurodegenerative diseases including Alzheimer’s.
Founded -Waltham, United States$530Mlast round Sept 2026Akero Therapeutics is a biotechnology company focused on reversing the NASH epidemic by restoring the body’s metabolism to a balanced state.
Founded 2017Cambridge, United States$502Mlast round Mar 2024Nuvalent is a biopharmaceutical company that develops targeted therapies for cancer by designing small-molecule medicines.
Founded 2017Cambridge, United States$500Mlast round Nov 2025Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments.
Founded 2014Cambridge, United States$485Mlast round Sept 2026Cerevel Therapeutics is a biopharmaceutical company that develops drugs to treat neurological and neuropsychiatric disorders.
Founded 2018Boston, United States$450Mlast round Oct 2023Laronde develops an eRNA-based therapeutic platform that is capable of indicating diverse proteins inside the body.
Founded 2017Cambridge, United States$440Mlast round Aug 2021Wave Life Sciences is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling diseases
Founded 2012Boston, United States$434Mlast round Dec 2025Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients.
Founded 2023Waltham, United States$420Mlast round Mar 2026PathAI develops technology that assists pathologists in making accurate diagnoses for every patient, every time.
Founded 2016Boston, United States$400Mlast round Jan 2022Parabilis Medicines is a Grupo Bugio is a biopharmaceutical firm that specializes in creating medicines.
Founded -Cambridge, United States$380Mlast round Jun 2026Iora Health is a primary care organization founded in 2010 or 2011, headquartered in Boston, Massachusetts.
Founded 2010Boston, United States$349Mlast round Feb 2020Editas Medicine is a clinical-stage genome editing company that develops genomic medicines for serious diseases.
Founded 2013Cambridge, United States$335Mlast round May 2026Solid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy.
Founded 2014Boston, United States$333Mlast round Mar 2026Morphic Therapeutic is a biotechnology company that develops oral integrin therapies to treat serious chronic diseases.
Founded 2015Waltham, United States$328Mlast round May 2023Beam Therapeutics is a biotechnology company developing precision genetic medicines through the use of base editing technology.
Founded 2017Cambridge, United States$322Mlast round Feb 2026Rhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeutics
Founded 2008Boston, United States$311Mlast round Jul 2025Fulcrum Therapeutics is a biotechnology company that focuses on identifying and treating rare genetic diseases at their root cause.
Founded 2016Cambridge, United States$310Mlast round Dec 2025Rubius has developed the technology to grow, genetically engineer and mature long-circulating Red-Cell Therapeutics.
Founded 2013Cambridge, United States$300Mlast round Mar 2021ReNAgade Therapeutics focuses on the boundless potential of RNA therapeutics to treat disease.
Founded 2021Cambridge, United States$300Mlast round May 2023Cullinan Therapeutics is a developer of an externally sourced cancer therapeutics used to end a drug program quickly.
Founded -Cambridge, United States$280Mlast round Apr 2024Disc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood disorders.
Founded 2017Watertown, United States$275Mlast round Oct 2025Strand Therapeutics is a biopharmaceutical company applying synthetic biology to RNA therapeutics to develop single dose mRNA treatments.
Founded 2017Cambridge, United States$267Mlast round Mar 2026Cardurion Pharmaceuticals is a clinical-stage biotechnology company founded in 2017, focused on developing innovative therapeutics for heart failure and other c
Founded 2017Burlington, United States$260Mlast round Jul 2024Compass Therapeutics is a biopharmaceutical company that focuses on drugging the immune system to treat human diseases.
Founded 2014Boston, United States$257Mlast round Aug 2025Stoke is developing antisense oligonucleotide medicines that target RNA splicing to increase gene expression for treatment.
Founded 2014Bedford, United States$255Mlast round Mar 2024Centessa Pharmaceuticals is a pharmaceutical company that focuses on drug development to address significant medical needs.
Founded 2021Cambridge, United States$250Mlast round Nov 2025Rapport Therapeutics is a clinical-stage biotechnology company that discovers and develops precision medicines for neurological disorders.
Founded 2022Boston, United States$250Mlast round Sept 2025TriNetX is a health research network that connects drug discovery and development from pharmaceutical companies.
Founded 2013Cambridge, United States$240Mlast round Apr 2026Seaport Therapeutics operates as a clinical stage biopharmaceutical company.
Founded 2024Boston, United States$240Mlast round Mar 2026Pear Therapeutics is a Massachusetts-based prescription digital therapeutic platform that offers solutions such as clinical engagement and patient tracking tool
Founded 2013Boston, United States$239Mlast round Dec 2021Odyssey Therapeutics creates precision immunomodulators and oncology medicines for patients with cancer and inflammatory diseases.
Founded 2021Boston, United States$238Mlast round May 2026LifeMine Therapeutics combines genomics with AI and synthetic biology to discover and develop a pipeline of novel medicines.
Founded 2016Cambridge, United States$230Mlast round Mar 2022Solstice Oncology develops immuno-oncology therapies focused on treating and preventing cancer through targeted approaches.
Founded -Boston, United States$225Mlast round Sept 2026Companies whose funding rounds we classed as any of these sectors, ranked by the total they have raised in rounds we hold. Nobody pays to be on a list.
Open any company for its rounds and investors, or search the investors who back health startups in Boston in the app, with filters, lists and exports.
GV
V
RPHealth startups worldwide12,811 companies · $81B
GV
V
RPHealth startups in the United States7,411 companies · $71B
ILO
NHHealth startups in Europe3,025 companies · $29B
IL
CS
ONHealth startups in the United Kingdom1,094 companies · $17B
AL
RM
FHealth startups in Bay Area959 companies · $33B
NH
OH
RHealth startups in New York406 companies · $14B
A
T
APHealth startups in Canada386 companies · $5.7BAL
E
AHealth startups in France379 companies · $8.4B
R
D
WStartups in Boston830 companies · $21B
R
S
DAI startups in Boston197 companies · $12B
W
ITCTBiotech startups in Boston125 companies · $10B
W
IT
PHealthcare startups in Boston99 companies · $7.8B
E
BIT Services startups in Boston76 companies · $1.7B
D
C
ABig Data & Analytics startups in Boston58 companies · $2.4B
WR
QC
TDeep tech startups in Boston39 companies · $1.8B
FE
GP
RREnergy startups in Boston37 companies · $4.5B